Dallas, February 1, 2024 – (Business Wire) – Valesco Industries is pleased to announce it has completed the sale of its interests in Drug Free Sport International (“DFSI”) to CPC.  Valesco made a control investment in DFSI in January 2017, and subsequently merged with IDTM, based in Stockholm, Sweden, in September 2018. Located in Kansas City, MO, DFSI is an international third-party administrator of unbiased and customized drug prevention/education and drug-testing programs for professional, collegiate, and amateur sports organizations, as well as a third-party service provider for clinical and mobile health services. 

During the time of our investment, the company accomplished major initiatives in the areas of people, processes and systems integrations while growing sales and EBITDA to company record levels. All the credit for these accomplishments goes to the stellar management team at DFSI who worked with Valesco to manage through merging with an international counterpart, a worldwide pandemic and diversification of its service offerings. Valesco has been proud to support a chapter in Drug Free Sport’s Mission – to “ensuring fair and safe sport and making mobile healthcare more accessible to all”.

“Valesco Industries has been instrumental in helping Drug Free Sport refine critical business processes, expand its value proposition and enable growth with supporting resources to enhance our position in the market. Valesco felt like a partner and was interested in the success and legacy of the business rather than returns.” – Chris Guinty, CEO Drug Free Sport International

At Valesco, we are inspired by high quality, family-founded and operated businesses looking for a partner to help them achieve the next level of growth. We could not be happier with the partnership and friendship we have built Drug Free Sport International and its people and wish them nothing but success in their future endeavors as a part of CPC. 

Boxwood Partners served as the exclusive advisor to Drug Free Sport and Valesco Industries.